Skip Navigation


Human Reproduction Update Advance Access originally published online on January 5, 2007
Human Reproduction Update 2007 13(3):313-327; doi:10.1093/humupd/dml057
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
13/3/313    most recent
dml057v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Carrell, D. T.
Right arrow Articles by Hammoud, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrell, D. T.
Right arrow Articles by Hammoud, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Altered protamine expression and diminished spermatogenesis: what is the link?

Douglas T. Carrell1,2,3,4, Benjamin R. Emery1,2 and Sue Hammoud1,2

1 Andrology and IVF Laboratories, Department of Surgery 2 Department of Physiology 3 Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT, USA

4 To whom correspondence should be addressed at: Andrology and IVF Laboratories, 675 S. Arapeen Dr, Suite #205, Salt Lake City, UT 84108, USA. E-mail: douglas.carrell{at}hsc.utah.edu

During the elongating spermatid stage of spermiogenesis, human sperm chromatin undergoes a complex transition in which histones are extensively replaced by protamines in a carefully regulated transition including histone modifications and intermediate and temporary replacement of the histones by sperm-specific transition proteins. The replacement of most histones by protamines 1 and 2 facilitates a high order of chromatin packaging necessary for normal sperm function and may also be necessary for DNA silencing and imprinting changes within the sperm cell. Protamines 1 and 2 are usually expressed in nearly equal quantities, but elevated or diminished protamine 1/protamine 2 ratios are observed in some infertile men and is often associated with severe spermatogenesis defects. Human and animal studies demonstrate that expression of the protamine proteins is uniquely regulated by transcription/translation factors, including storage of the mRNA in ribonucleoprotein (RNP) particles composed of the mRNA, transcription factors and a kinesin molecule necessary for transport of the RNP to the cytoplasm and removal of transcriptional activators from the nucleus. Recent studies indicate that most patients with abnormal protamine protein levels have elevated levels of protamine transcript in the mature sperm cell, indicating a possible defect in transcription or translation. The regulation of protamine expression is unique and includes several possible mechanisms which may be responsible for dysregulation of protamine expression and concurrent broad spectrum defects in spermatogenesis. We suggest two hypotheses: (i) that abnormal protamine expression is indicative of a generalized defect in mRNA storage and/or translation which affects other mRNA transcripts or (ii) that protamines may act as a checkpoint of spermatogenesis.

Key words: chromatin / gene expression / protamine / spermatogenesis / transition protein

Received on September 15, 2006; revised October 20, 2006; accepted on November 7, 2006


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J AndrolHome page
D. T. Carrell
The Clinical Implementation of Sperm Chromosome Aneuploidy Testing: Pitfalls and Promises
J Androl, March 1, 2008; 29(2): 124 - 133.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C. Ravel, S. Chantot-Bastaraud, B. El Houate, I. Berthaut, L. Verstraete, V. De Larouziere, D. Lourenco, A. Dumaine, J.M. Antoine, J. Mandelbaum, et al.
Mutations in the protamine 1 gene associated with male infertility
Mol. Hum. Reprod., July 1, 2007; 13(7): 461 - 464.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.